Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?

April 2012

Critical Access Hospitals Losing Lab Test Work

Laboratory Management / By

CEO SUMMARY: One consequence of a new “site of service” health plan instituted by Anthem Blue Cross and Blue Shield in New Hampshire is that community hospitals—particularly in rural areas—are being asked by patients to collect blood and lab specimens, then send them off to Anthem’s network laboratories. One New Hampshire hospital CEO explains how …

Critical Access Hospitals Losing Lab Test Work Read More »

To access this post, you must purchase The Dark Report.

Ohio Lab Offers Lessons Learned from CAP 15189

Laboratory Management / By

CEO SUMMARY: For a lab looking to continually improve lab operations, becoming accredited to either ISO 15189 or CAP 15189 is an ideal challenge. After hearing from other lab directors about the benefits of becoming accredited to CAP 15189, the staff at Mercy Medical Center in Canton, Ohio, believed that accreditation to this standard would …

Ohio Lab Offers Lessons Learned from CAP 15189 Read More »

To access this post, you must purchase The Dark Report.

LifeLabs, Gamma-Dynacare, Sonic Healthcare, Brigham & Women’s Hospital, Massachusetts General Hospital

Clinical Laboratory / By

LIFELABS QUEBEC TO BE ACQUIRED BY GAMMA-DYNACARE LAST WEEK, IT WAS ANNOUNCED that Gamma-Dynacare Medical Laboratories had signed a definitive agreement with LifeLabs Limited Partnership to purchase LifeLabs Quebec. Both parties expect the transaction to close by April 28, 2012. This laboratory acquisition is notable for at least three reasons. First, it involves Canada’s two primary …

LifeLabs, Gamma-Dynacare, Sonic Healthcare, Brigham & Women’s Hospital, Massachusetts General Hospital Read More »

To access this post, you must purchase The Dark Report.

Exome Sequencing Next “Big Thing” for Diagnosis

Genetic Testing / By

CEO SUMMARY: For disease diagnostics, exome sequencing is not yet routine, but geneticists are getting close. Using this technology, researchers read those parts of the human genome where about 85% of disease-causing mutations reside. By looking only at the regions that encode proteins—the workhorse machinery of the cell—researchers identify dis- ease causes much faster than …

Exome Sequencing Next “Big Thing” for Diagnosis Read More »

To access this post, you must purchase The Dark Report.

April 2, 2012 “Intelligence: Late Breaking Lab News”

Late Breaking Lab News / By

Like a tenacious bulldog, Roche Holding AG continues its determined effort to acquire Illumina, Inc., the company that makes gene sequencing systems. Last week, Roche increased its offer from $44.50 per share to $51 per share for Illumina stock. That raises the price Roche says it will pay to $6.5 billion, which is 15% greater …

April 2, 2012 “Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

Facebook-f Twitter Linkedin-in

The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: customerservice@darkintelligencegroup.com

© 2022 The Dark Report. All rights reserved.

;